Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 27, Issue 6, Pages 1079-1087
Publisher
Springer Science and Business Media LLC
Online
2021-06-15
DOI
10.1038/s41591-021-01391-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reductions in insulin resistance are mediated primarily via weight loss in subjects with type 2 diabetes on semaglutide
- (2019) Vivian A Fonseca et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials
- (2018) Vanita R. Aroda DIABETES OBESITY & METABOLISM
- Quality of life related to oral, subcutaneous, and intravenous biologic treatment of inflammatory bowel disease
- (2018) Przemysław Holko et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Effect of liraglutide on ambulatory blood pressure in hypertensive patients with type 2 diabetes: randomized, double blind, placebo-controlled trial
- (2018) Aris Liakos et al. DIABETES OBESITY & METABOLISM
- Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
- (2018) Stephen T. Buckley et al. Science Translational Medicine
- LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
- (2018) Tamer Coskun et al. Molecular Metabolism
- Discovery, characterization, and clinical development of the glucagon-like peptides
- (2017) Daniel J. Drucker et al. JOURNAL OF CLINICAL INVESTIGATION
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
- (2016) Michael Nauck et al. DIABETES CARE
- Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series
- (2016) Sudha S. Shankar et al. DIABETES CARE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide Promotes Natriuresis but Does Not Increase Circulating Levels of Atrial Natriuretic Peptide in Hypertensive Subjects With Type 2 Diabetes
- (2014) Julie A. Lovshin et al. DIABETES CARE
- A Novel Humanized GLP-1 Receptor Model Enables Both Affinity Purification and Cre-LoxP Deletion of the Receptor
- (2014) Lucy S. Jun et al. PLoS One
- Type 2 Diabetes Mellitus and Hypertension
- (2013) Guido Lastra et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
- (2013) M E J Lean et al. INTERNATIONAL JOURNAL OF OBESITY
- A Model-Based Approach to Predict Longitudinal HbA1c, Using Early Phase Glucose Data From Type 2 Diabetes Mellitus Patients After Anti-Diabetic Treatment
- (2013) Maria C. Kjellsson et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A semi-mechanistic model of the relationship between average glucose and HbA1c in healthy and diabetic subjects
- (2013) Rocío Lledó-García et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Achievement of Goals in U.S. Diabetes Care, 1999–2010
- (2013) Mohammed K. Ali et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization
- (2009) Catherine E. Cooke et al. CURRENT MEDICAL RESEARCH AND OPINION
- Endogenous Glucagon-Like Peptide-1 Slows Gastric Emptying in Healthy Subjects, Attenuating Postprandial Glycemia
- (2009) Adam M. Deane et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Translating the A1C Assay Into Estimated Average Glucose Values
- (2008) D. M. Nathan et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More